Literature DB >> 2562849

Clonal expansion of human T lymphocytes initiated by dendritic cells.

E Langhoff1, R M Steinman.   

Abstract

The accessory cell requirements for cloning T cells in the presence of lectin and T cell growth factors were examined with cells from human peripheral blood. We found that dendritic cells were active and perhaps essential. Single CD4+ lymphocytes could be cloned with 80% efficiency, and CD8+ cells with 50-60% efficiency if 10(3) syngeneic or allogeneic dendritic cells were added. Some T cell clones developed even with one dendritic cell. Monocytes or B lymphocytes from blood were at least 100-fold weaker in supporting clonal growth. These findings suggest a specialized feeder cell requirement, namely dendritic cells, for cloning T lymphocytes from single resting precursors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562849      PMCID: PMC2189191          DOI: 10.1084/jem.169.1.315

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Antibody production by single cells.

Authors:  G J NOSSAL; J LEDERBERG
Journal:  Nature       Date:  1958-05-17       Impact factor: 49.962

2.  Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction.

Authors:  E R Flechner; P S Freudenthal; G Kaplan; R M Steinman
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

3.  Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells.

Authors:  J W Young; R M Steinman
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

Review 4.  Antigen-specific, proliferating T lymphocyte clones. Methodology, specificity, MHC restriction and alloreactivity.

Authors:  B Sredni; R H Schwartz
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

5.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

6.  Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.

Authors:  W C Van Voorhis; J Valinsky; E Hoffman; J Luban; L S Hair; R M Steinman
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

7.  The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light-microscopic immunocytochemical studies of mouse spleen, lymph node, and Peyer's patch.

Authors:  M D Witmer; R M Steinman
Journal:  Am J Anat       Date:  1984-07

8.  Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation.

Authors:  J M Austyn; R M Steinman; D E Weinstein; A Granelli-Piperno; M A Palladino
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone.

Authors:  J M Austyn; J W Kupiec-Weglinski; D F Hankins; P J Morris
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.

Authors:  K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  18 in total

1.  An approach to isolating T cell lines that react to antigens presented on the surface of dendritic cells.

Authors:  P Pancholi; R M Steinman; N Bhardwaj
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

2.  Tolerogenicity of resting and activated B cells.

Authors:  K M Gilbert; W O Weigle
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

3.  Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion.

Authors:  E Langhoff; J McElrath; H J Bos; J Pruett; A Granelli-Piperno; Z A Cohn; R M Steinman
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

4.  Pneumonitis in human cytomegalovirus infection.

Authors:  Erik Langhoff; Robert E Siegel
Journal:  Curr Infect Dis Rep       Date:  2006-05       Impact factor: 3.725

5.  Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein.

Authors:  G Mosialos; M Birkenbach; S Ayehunie; F Matsumura; G S Pinkus; E Kieff; E Langhoff
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

6.  Lymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cells.

Authors:  S M Hsu; P L Hsu
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

7.  Dendritic cells efficiently immunoselect mycobacterial-reactive T cells in human blood, including clonable antigen-reactive precursors.

Authors:  P Pancholi; R M Steinman; N Bhardwaj
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

8.  Different growth factor requirements for human Th2 cells may reflect in vivo induced anergy.

Authors:  F C Van Reijsen; O L Wijburg; M Gebhardt; A G Van Ieperen-Van Dijk; S Betz; E M Poellabauer; T Thepen; C A Bruijnzeel-Koomen; G C Mudde
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

9.  During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion.

Authors:  P U Cameron; U Forsum; H Teppler; A Granelli-Piperno; R M Steinman
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

10.  Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

Authors:  E Langhoff; E F Terwilliger; H J Bos; K H Kalland; M C Poznansky; O M Bacon; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.